Efficacy and Time and Resources for Hylenex-facilitated SC Rehydration Versus ORT for Dehydrated Children in the Emergency Department (ED)

NCT01120431 ↗

Phase 4 Withdrawn Baxter Healthcare Corporation Halozyme Therapeutics · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose is to evaluate the safety and efficacy as well as the time and resources needed in the ED setting to achieve rehydration in young pediatric subjects with mild to moderate dehydration using hylenex-facilitated SC rehydration versus oral rehydration therapy.

Timeline

Start: 2010-05
Primary completion: 2010-05
Completion: 2010-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	rHuPH20	Protein / enzyme biologic	150 iu	Subcutaneous

Indications

No indication recorded.